2024年12月19日,中国北京——恩颐投资宣布与Aisling Capital及Blue Owl Healthcare Opportunities共同完成对美国临床阶段免疫肿瘤技术研发商Marker Therapeutics的战略投资。此次投资将助力Marker Therapeutics进一步推进其过继性非基因修饰T细胞疗法在治疗恶性血液病,如急性髓性白血病、淋巴瘤和多发性骨髓瘤等领域的临床应用。 M...
Blue Owl Capital is an asset manager focused on providing private capital solutions across various sectors including credit, strategic capital, and real estate. Use the CB Insights Platform to explore Blue Owl Capital's full profile.
2. Blue Owl Real Estate’s investment strategy will target NNN as well as NN Roof & Structure properties. 3. Investment grade companies must have “BBB-” rating or higher by S&P or an equivalent rating from a nationally recognized statistical rating organization (NRSRO). Creditworthy refers to...
Blue Owl is different from your regular SPAC because it is being formed via the merger ofthreecompanies rather than the usual two. One is the SPAC sponsor, the vehicle through which the others go public—Altimar Acquisition Corporation. Another is Owl Rock, a direct lending platform which lend...
Blue Owl Capital (OWL) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Blue Owl Capital is a US-based Private Equity Firm. The firm operates the following four investment strategies: GP minority equity investments, GP debt finan...